• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[ANTIANHEDONIC EFFECT OF 3-OXYPYRIDINE AND SUCCINIC ACID DERIVATIVES].

作者信息

Volchegorskii I A, Miroshnichenko I Yu, Rassokhina L M, Faizullin R M, Pryakhina K E

出版信息

Ross Fiziol Zh Im I M Sechenova. 2016 Nov;102(11):1312-22.

PMID:30193447
Abstract

We performed a comparative study of the effect of original domestic derivatives of 3-oxypyri-dine and succinic acid (emoxipine, reamberin and mexidol) on measures from «sucrose preferen-ce» test which is used for assessment of hedonic behavior in rats. а-lipoic acid (а-LA) and amit-riptylin were used as reference medications. For the modeling of anhedonia rats received dexa-methasone (5 mg/kg subcutaneously). We established that threefold administration of emoxipine, reamberin and mexidol in doses that are equivalent to therapeutic range in humans had antianhe-donic effect and increased the measures of «preference» and absolute sucrose consumption. This effect was demonstrated in animals that did not receive dexamethasone as well as in rats with dexamethasone-induced anhedonia. Maximal intensity of antianhedonic effect of 3-oxypyridine and succinic acid derivatives was noted after the previous administration of dexamethasone. In rats that did not receive dexamethasone, succinate-containing medications (reamberin and mexidol) exceeded the isolated 3-oxypyridine derivative (emoxipine) in their antianhedonic potential. In case of previous dexamethasone administration 3-oxypyridine and succinic acid derivatives demonstrated equivalent antianhedonic effect that exceeded the effect of reference medications (а-LA and amitriptylin).

摘要

相似文献

1
[ANTIANHEDONIC EFFECT OF 3-OXYPYRIDINE AND SUCCINIC ACID DERIVATIVES].
Ross Fiziol Zh Im I M Sechenova. 2016 Nov;102(11):1312-22.
2
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].[3-氧代吡啶与琥珀酸衍生物的抗抑郁作用(实验研究)]
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(2):48-52. doi: 10.17116/jnevro20151152148-52.
3
[Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus].[依莫昔平、雷美替胺和美西多宁在实验性糖尿病中的抗焦虑和抗抑郁作用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):52-57. doi: 10.17116/jnevro20171175152-57.
4
[Insulin potentiating and antidepressant effects of 3-oxypyridine and succinic acid derivatives].[3-氧代吡啶和琥珀酸衍生物的胰岛素增强及抗抑郁作用]
Eksp Klin Farmakol. 2014;77(5):6-9.
5
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].[3-氧代吡啶和琥珀酸衍生物对大鼠四氧嘧啶诱导的糖尿病急性期的脑保护作用]
Eksp Klin Farmakol. 2011;74(5):17-25.
6
[Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].[3-氧代吡啶和琥珀酸衍生物在实验性糖尿病中的脑保护作用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(6):50-61.
7
[The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].[3-氧代吡啶和琥珀酸衍生物对小鼠大理石埋藏试验中强迫行为的影响]
Eksp Klin Farmakol. 2014;77(10):10-4.
8
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].[3-氧代吡啶与琥珀酸衍生物在四氧嘧啶糖尿病中的抗焦虑和抗抑郁作用]
Ross Fiziol Zh Im I M Sechenova. 2015 Mar;101(3):258-67.
9
[The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].[3-氧代吡啶和琥珀酸衍生物对急性脑缺血耐受性的影响]
Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(12):123-127. doi: 10.17116/jnevro2014114121123-127.
10
[Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].[3-氧代吡啶和琥珀酸衍生物对大鼠四氧嘧啶诱导糖尿病急性期的抗焦虑和抗抑郁作用]
Eksp Klin Farmakol. 2014;77(4):14-20.